Keystone Financial Planning, Inc. Amgen Inc Transaction History

Keystone Financial Planning, Inc.

$314 Million
Q4 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 11, 2023	BUY	$214.27 - $253.37 $75,208 - $88,932	351 Added 1.15%	30,866 $6.85 Million
Q1 2023 Apr 21, 2023	BUY	$225.79 - $275.2 $6.89 Million - $8.4 Million	30,515 New	30,515 $7.38 Million
Q3 2022 Oct 12, 2022	SELL	$224.46 - $253.15 $6.83 Million - $7.7 Million	-30,421 Reduced 90.31%	3,264 $736,000
Q2 2022 Jul 19, 2022	SELL	$230.71 - $256.74 $40,143 - $44,672	-174 Reduced 0.51%	33,685 $8.2 Million
Q1 2022 Apr 28, 2022	SELL	$219.27 - $242.57 $61,614 - $68,162	-281 Reduced 0.82%	33,859 $8.19 Million
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $6.39 Million - $7.31 Million	32,113 Added 1584.26%	34,140 $7.68 Million
Q3 2021 Oct 15, 2021	BUY	$212.27 - $248.7 $430,271 - $504,114	2,027 New	2,027 $431,000
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $204,148 - $226,488	-874 Closed	0 $0
Q2 2020 Jul 27, 2020	SELL	$197.81 - $242.74 $158,841 - $194,920	-803 Reduced 47.88%	874 $206,000
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $3.04 Million - $4.04 Million	-16,702 Reduced 90.88%	1,677 $340,000
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $49,383 - $63,475	-261 Reduced 1.4%	18,379 $4.43 Million
Q3 2019 Oct 08, 2019	SELL	$174.11 - $208.62 $50,840 - $60,917	-292 Reduced 1.54%	18,640 $3.61 Million
Q2 2019 Aug 05, 2019	SELL	$166.7 - $195.41 $51,176 - $59,990	-307 Reduced 1.6%	18,932 $3.49 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $1.24 Million - $1.4 Million	-6,856 Reduced 26.27%	19,239 $3.66 Million
Q4 2018 Feb 05, 2019	SELL	$178.4 - $208.25 $396,940 - $463,356	-2,225 Reduced 7.86%	26,095 $5.08 Million
Q3 2018 Nov 02, 2018	BUY	$185.29 - $208.89 $63,739 - $71,858	344 Added 1.23%	28,320 $5.87 Million
Q2 2018 Aug 06, 2018	BUY	$166.05 - $186.51 $171,695 - $192,851	1,034 Added 3.84%	27,976 $5.16 Million
Q1 2018 May 01, 2018	BUY	$169.43 - $198.0 $205,349 - $239,976	1,212 Added 4.71%	26,942 $4.59 Million
Q4 2017 Feb 07, 2018	BUY	$168.79 - $188.59 $3.93 Million - $4.39 Million	23,297 Added 957.54%	25,730 $4.47 Million
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $407,016 - $464,703	2,433	2,433 $454,000

Others Institutions Holding AMGN

# of Institutions

3,097

Shares Held

406M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keystone Financial Planning, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Keystone Financial Planning, Inc. with notifications on news.

Account